HCW Biologics (HCWB) Receivables - Net (2020 - 2025)
HCW Biologics (HCWB) has disclosed Receivables - Net for 6 consecutive years, with $30667.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Net fell 95.3% year-over-year to $30667.0, compared with a TTM value of $30667.0 through Sep 2025, down 95.3%, and an annual FY2024 reading of $582201.0, down 62.09% over the prior year.
- Receivables - Net was $30667.0 for Q3 2025 at HCW Biologics, up from $21611.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $1.5 million in Q4 2023 and bottomed at $21611.0 in Q2 2025.
- Average Receivables - Net over 5 years is $448035.2, with a median of $386625.0 recorded in 2022.
- The sharpest move saw Receivables - Net skyrocketed 593.87% in 2022, then tumbled 96.7% in 2025.
- Year by year, Receivables - Net stood at $133000.0 in 2021, then surged by 214.06% to $417695.0 in 2022, then skyrocketed by 267.67% to $1.5 million in 2023, then tumbled by 62.09% to $582201.0 in 2024, then crashed by 94.73% to $30667.0 in 2025.
- Business Quant data shows Receivables - Net for HCWB at $30667.0 in Q3 2025, $21611.0 in Q2 2025, and $87493.0 in Q1 2025.